The enhanced permeability retention effect: a new paradigm for drug targeting in infection.
about
Gram negative wound infection in hospitalised adult burn patients--systematic review and metanalysis-Polymer therapeutics in surgery: the next frontierActive targeted drug delivery for microbes using nano-carriersStimuli-responsive nanomaterials for biomedical applicationsDetection and quantification of bacterial biofilms combining high-frequency acoustic microscopy and targeted lipid microparticles.Polyglycerol-opioid conjugate produces analgesia devoid of side effectsSelective recognition of anionic cell membranes using targeted liposomes coated with zinc(ii)-bis(dipicolylamine) affinity units.Nanomedicine in the Management of Microbial Infection - Overview and PerspectivesNanoparticle approaches against bacterial infectionsDevelopment and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.Principles of nanoparticle design for overcoming biological barriers to drug deliveryBiomimetic proteolipid vesicles for targeting inflamed tissuesHypoxia promotes tumor cell motility via RhoA and ROCK1 signaling pathways.Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude miceMultiple strategies to activate gold nanoparticles as antibiotics.Polymer-Based and pH-Sensitive Nanobiosensors for Imaging and Therapy of Acidic Pathological Areas.Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics.Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation.An "On-Site Transformation" Strategy for Treatment of Bacterial Infection.Targeted, triggered drug delivery to tumor and biofilm microenvironments.Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.Computer-aided design of liposomal drugs: In silico prediction and experimental validation of drug candidates for liposomal remote loading.Mononuclear Polypyridylruthenium(II) Complexes with High Membrane Permeability in Gram-Negative Bacteria-in particular Pseudomonas aeruginosa.Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound.Novel poly(vinyl alcohol)-based amphiphilic nanogels by non-covalent boric acid crosslinking of polymeric micelles.Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.Oligonuclear polypyridylruthenium(II) complexes: selectivity between bacteria and eukaryotic cells.Nanotherapeutics for multiple myeloma.Leveraging Physiology for Precision Drug DeliveryQuaternized Silicon Nanoparticles with Polarity-Sensitive Fluorescence for Selectively Imaging and Killing Gram-Positive Bacteria
P2860
Q26864465-58E69B97-C488-4CA7-857A-CE58DBD2B90EQ28067866-4A9CCD26-777D-4F1C-9B6D-56B1EF488CBCQ28082463-815EE67F-1C55-4F85-ACB7-D589D0C14D4CQ30396768-DF151719-3165-43C3-BAA3-F62216C1522DQ30411408-7150AD27-6998-4CD7-BCB0-ABDC946A9E07Q33870260-C3AB5BDF-F4FB-402D-A880-8A7070210E02Q34026778-AC8ED620-0D55-4CC4-9616-E412697C9F53Q34245494-E76864DA-C42E-4EA1-8AF8-5CE37AB39105Q34339159-0A9901BD-6C16-4C0F-B3A4-C52029AC485AQ35169065-86D00C39-1CFA-4A8B-8FEB-1A7563EFD057Q36409837-D9C4BC8B-8CAE-462A-96A6-3A86E07BEAA1Q36791673-B0E4C62D-0483-4F20-9308-B161F10F5227Q37162182-C91A35BF-825A-4188-A9D8-BFE733B639C5Q37451394-FAF7187B-07C6-44BF-949C-DC2FA56C04B9Q37519522-A5D205AC-FE52-4734-AC14-9FC66FEA5CC9Q37609755-48B722CC-E7E8-4BE5-A991-5E02B611E571Q38124738-5303BECE-75E1-4E4D-B229-0542BD309056Q38835419-0698EC47-E5DB-423C-8E04-D96C7DD06003Q38853138-B8709289-65E4-4F6E-AA44-95141C1BFE37Q39084192-DF79F35E-5C7B-4B01-8A6F-774B9A3164D2Q39414836-3848AC47-DC23-4E51-847D-03FA86D11F6CQ40090893-D955DC67-88BD-488A-9D84-6E4CBECCC0ADQ40104216-E92A7C33-2CEB-4D95-9948-738BFE53D687Q40751256-6F0E704F-6E8F-4C6D-A847-6B323BEA03BFQ41554387-4CE44448-D35E-4E8D-BC3D-368EE7471E39Q42881401-D456D76F-F04D-4B02-B20C-A67523327481Q46719583-4C0160EC-ACE0-48F9-BA03-FC0F632CBCC3Q47138349-34122432-D9AA-4C3A-B99D-3A7243848908Q47580663-327804C2-1DD2-421F-B0F8-250ABA2B48B8Q49788067-5CB46B56-C9B4-4BC2-A97B-AAC79336617DQ50203884-0ABD2ABC-9DA6-43EF-AE43-3A2210526D38Q52559684-7C06DBAA-252A-43EE-AF04-55FA80148601Q57428850-37CFD852-AE1A-423B-83E4-0BC2A59ACF85Q57974210-BF8F393E-D627-42BE-958D-BE6F3DA5053B
P2860
The enhanced permeability retention effect: a new paradigm for drug targeting in infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The enhanced permeability rete ...... r drug targeting in infection.
@en
type
label
The enhanced permeability rete ...... r drug targeting in infection.
@en
prefLabel
The enhanced permeability rete ...... r drug targeting in infection.
@en
P2860
P50
P356
P1476
The enhanced permeability rete ...... or drug targeting in infection
@en
P2093
David W Thomas
P2860
P304
P356
10.1093/JAC/DKS379
P407
P577
2012-10-10T00:00:00Z